US20030191439A1 - Disposable device for transferring an active liquid into a body cavity - Google Patents

Disposable device for transferring an active liquid into a body cavity Download PDF

Info

Publication number
US20030191439A1
US20030191439A1 US10/400,446 US40044603A US2003191439A1 US 20030191439 A1 US20030191439 A1 US 20030191439A1 US 40044603 A US40044603 A US 40044603A US 2003191439 A1 US2003191439 A1 US 2003191439A1
Authority
US
United States
Prior art keywords
liquid
body cavity
vagina
source
expandable element
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/400,446
Inventor
Bernard Chaffringeon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US10/400,446 priority Critical patent/US20030191439A1/en
Publication of US20030191439A1 publication Critical patent/US20030191439A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/2022Tampons, e.g. catamenial tampons; Accessories therefor characterised by the shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/2051Tampons, e.g. catamenial tampons; Accessories therefor characterised by the material or the structure of the inner absorbing core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/20Tampons, e.g. catamenial tampons; Accessories therefor
    • A61F13/2074Tampons, e.g. catamenial tampons; Accessories therefor impregnated with hydrophobic, hydrophilic, skin enhancers, medicinal etc. substances
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S604/00Surgery
    • Y10S604/904Tampons

Definitions

  • the present invention relates to the transfer or circulation of an active liquid into or in a body cavity of the human body or of an animal, particularly in contact with the mucous membrane of said cavity.
  • body cavity is to be understood as meaning any bodily cavity, particularly an elongate one, which can be accessed externally for various purposes, particularly clinical, therapeutic, prophylactic or diagnostic, but also for cosmetic or personal hygiene purposes.
  • a cavity mention may be made of the woman's vagina extending from the vulva to the neck of the uterus, into which an active liquid is to be transferred or in which an active liquid is to be circulated, in contact with the mucous membranes or tissues of said cavity.
  • active liquid is to be understood as meaning any liquid or fluid for treatment, either locally via a topical route, or systemically and in general comprising a liquid or fluid phase in which a treatment agent is distributed in solution or in suspension.
  • This treatment agent is chosen from the group consisting of wetting agents, agents for solubilizing and fluidizing particularly a bodily fluid or liquid present in the body cavity, therapeutic, prophylactic and diagnostic agents, cosmetic or personal hygiene agents, antiseptics, bactericides, fungicides and spermicides (in the case of the woman's vagina cavity for example).
  • a subject of the present invention is a disposable device allowing better availability of the active principle or principles in contact with the mucous membrane of the wall of the body cavity, particularly when the treatment agent is therapeutic agent.
  • Another object of the invention is a device which ensures an almost total absence of external flow of the active liquid and/or of the bodily fluid or of any liquid present in the body cavity in question, throughout the time that said device is present or held in this cavity, simply by constriction thereof.
  • the disposable device has sufficient intrinsic consistency that it can be inserted into the body cavity by pushing, and comprises:
  • a central element at the source of at least part of the active liquid in that it comprises a substrate which is relatively solid at ambient temperature and outside the body cavity, and becomes relatively liquid or fluid inside this same cavity and at body temperature so that within this cavity the central element liquefies at least partially to generate at least part of the liquid phase of the active liquid,
  • FIG. 1 depicts a disposable device according to the invention, in position in a body cavity, and just after it has been inserted into the latter by pushing, this being according to a first embodiment of the invention;
  • FIG. 1 is an axial section through a device according to the invention, the latter having symmetry of revolution about an axis;
  • FIGS. 2 to 4 respectively depict three other embodiments of the present invention, still in axial section;
  • FIG. 5 depicts another embodiment of the present invention, still in axial section.
  • a disposable device is referenced by the numerical reference 1 .
  • it allows an active liquid as previously defined to be dispensed or released into a body cavity denoted by the numerical reference 2 .
  • This device has an intrinsic and overall consistency which is relatively firm but soft and stiff or strong enough to allow it to be inserted into the cavity by pushing, without altering the structure of said device, particularly without dissociating its various components and/or rupturing any liquid-containing capsule that may be contained inside said device (cf. embodiment according to FIG. 4).
  • the device according to the invention essentially comprises two components assembled together permanently, namely:
  • a peripheral element 4 arranged around the central element 3 comprising a pad 5 designed to absorb the active liquid which has circulated or been dispensed into the body cavity, by expanding and thus coming to press in a relatively sealed manner against the mucous membrane of the body cavity (cf. shape depicted in dotted line in FIG. 1).
  • the central element 3 comprises a substrate, for example based on gelatin, which is relatively solid at ambient temperature and outside the body cavity and which becomes relatively liquid inside the body cavity and at body temperature so that within this cavity the central element liquefies at least partially to generate at least part of the liquid phase of the active liquid.
  • the gelatin may be replaced by any other substrate with the same properties, for example a lipid.
  • the substrate of the central element which, by liquefaction within the body cavity, and therefore within the human body or the body of the animal, makes it possible to obtain all or part of the liquid phase of the active liquid.
  • an agent for treating the body cavity as previously described is distributed discretely in the solid substrate of the central element, this being so regardless of the physical form or nature of said treatment agent outside the substrate, for example an oily, solid or liquid physical form, or whether it is hydrophobic or hydrophilic by nature.
  • This discrete distribution of the treatment agent may be achieved by incorporating this agent into the previously defined substrate in the liquid phase when the disposable device according to the invention is being manufactured.
  • the central element 3 is a kind of molded part, molded by the solidification of the liquid substrate, for example the gelatin.
  • the pad 5 is a sleeve also molded or shaped from a material capable of absorbing a liquid or a fluid as it expands.
  • This material is, for example, a foam of a biocompatible plastic material or alternatively a fibrous material (for example of the cellulose type), opened (for example folded) around the central element 3 .
  • the central element 3 and the peripheral element 4 are thus tailored to one another so that they fit together by simple axial pushing of the central element toward the peripheral element or vice versa.
  • the peripheral element 4 has a hole 4 a , or bore, particularly a blind hole as shown in FIG. 1, the shape and size of which are tailored correspondingly to receive the body 3 a of the central element 3 .
  • the head 3 b of the central element 3 of convex external shape, for example spherical, has a collar 6 while the peripheral element 4 has a neck 7 , the shape and size of which are tailored to definitively retain the collar 6 , by axially pushing the central element 3 and peripheral element 4 together.
  • the neck 7 has an undercut accommodating the collar 6 directed inward, and also of convex external shape, for example spherical.
  • the foot 3 c of the central element 3 has a bulging shape, while the peripheral element 4 has a correspondingly flared part 4 d , the shape and size of which are tailored to retain the foot 3 c of the central element 3 .
  • the absorbent material of the pad 5 can expand and/or is spongy and consists, for example, of filaments, capillary fibers, or natural fibers (cellulose or viscose for example), etc. As mentioned earlier, it is the liquefaction or melting of the substrate of the central element 3 which, generating at least part of the liquid phase of the active liquid within the body cavity 2 , then allows the pad 5 to expand by collecting said liquid therein, this being the case at body temperature and inside the body cavity 2 .
  • the pad 5 is bored for example with four radial passages 11 in a cross configuration, located below the hole 4 a , opening onto the exterior face of the pad 5 and possibly communicating with the bottom of the hole 4 a.
  • the collar 6 extends toward the foot 3 c of the central element 3 in the form of a skirt 6 a capping the part 4 b of the peripheral element 4 away from the neck 7 .
  • a string 12 attached to the peripheral element 4 allows the disposable device 1 to be extracted from the body cavity 2 after it has treated the latter, that is to say after the substrate of the central element 3 has liquefied.
  • a closed temporary protective case 10 encases the central element 3 and peripheral element 4 when these elements are assembled, as described earlier.
  • This casing consists, for example, of a substrate with the properties described above, for example based on gelatin. What this means is that the casing is made of a material which is relatively solid at ambient temperature and outside the body cavity so that within this cavity and at the body temperature, this material melts and thus constitutes another part of the liquid phase of the active liquid previously defined.
  • this casing 10 may consist of a hard and solid excipient, for example sucrose, as used in a galenic form to obtain sugar-coated pills, and capable of dissolving or breaking up in contact with any bodily liquid present in the cavity 2 .
  • the central element 3 is a capsule, the wall 8 of which consists of the previously defined substrate and the interior of which contains another liquid 15 , active or otherwise, the wall 8 being closed and sealed at ambient temperature and outside the body.
  • the liquid thus contained in the capsule makes it possible to increase the amount of liquid phase of the active liquid.
  • This liquid 15 may have any appropriate form, for example oily, and may contain all or part of a treatment agent as previously described, in solution or in suspension in said liquid.
  • the casing 10 depicted in FIG. 4 may be omitted, while the wall 8 forms an appendage 13 that can be broken off at its opposite end of the pad 5 , which allows the user to open the capsule just before inserting the device into the body cavity and to benefit from a small amount of the liquid 15 to moisten the exterior of said device at the time of inserting it into said cavity.
  • a device according to the invention prior to its insertion into the body cavity 2 , comprises a distal part 1 a , via which it is inserted into the body cavity 2 , and a proximal part 1 b , the largest transverse diameter of which is smaller than the largest transverse diameter of the distal part 1 a . This allows the device to be held temporarily in the cavity before the active liquid takes over by swelling the pad 5 .
  • This configuration also makes it possible to limit or eliminate any contact between the mucous membrane of the body cavity 2 and the absorbent material when the pad 5 is in the dry state at the time of insertion of the device 1 ; as such contact could not only give rise to a not insignificant amount of friction but may also be a source of discomfort or pain to the user.
  • it is only the distal part 1 a , covered with the relatively slippery collar 7 , which slides in contact with the mucous membrane of the body cavity as the device is being inserted.
  • a disposable device as previously described affords the following essential advantages:

Abstract

A disposable device for transferring an active liquid into a body cavity has sufficient intrinsic consistency for being inserted by being thrust into the cavity. The device includes a central element, that is the source of at least part of the active liquid. The central element is preferably formed from a capsule having a wall that forms a detachable appendage. A peripheral element is arranged around the central element. The peripheral element may be a pad arranged to collect and absorb active liquid delivered into the body cavity by expanding and thereby being urged to press sealingly against mucous membrane of the body cavity.

Description

  • This application is a continuation of U.S. patent application Ser. No. 09/830,426, which is the National Stage of International Application No. PCT/FR00/00245, filed Feb. 2, 2000. The entire disclosure of the prior application is hereby incorporated by reference herein in its entirety.[0001]
  • SUMMARY OF THE INVENTION
  • The present invention relates to the transfer or circulation of an active liquid into or in a body cavity of the human body or of an animal, particularly in contact with the mucous membrane of said cavity. [0002]
  • The term “body cavity” is to be understood as meaning any bodily cavity, particularly an elongate one, which can be accessed externally for various purposes, particularly clinical, therapeutic, prophylactic or diagnostic, but also for cosmetic or personal hygiene purposes. By way of an example of such a cavity, mention may be made of the woman's vagina extending from the vulva to the neck of the uterus, into which an active liquid is to be transferred or in which an active liquid is to be circulated, in contact with the mucous membranes or tissues of said cavity. [0003]
  • In consequence, the term “active liquid” is to be understood as meaning any liquid or fluid for treatment, either locally via a topical route, or systemically and in general comprising a liquid or fluid phase in which a treatment agent is distributed in solution or in suspension. This treatment agent is chosen from the group consisting of wetting agents, agents for solubilizing and fluidizing particularly a bodily fluid or liquid present in the body cavity, therapeutic, prophylactic and diagnostic agents, cosmetic or personal hygiene agents, antiseptics, bactericides, fungicides and spermicides (in the case of the woman's vagina cavity for example). [0004]
  • A subject of the present invention is a disposable device allowing better availability of the active principle or principles in contact with the mucous membrane of the wall of the body cavity, particularly when the treatment agent is therapeutic agent. [0005]
  • Another object of the invention is a device which ensures an almost total absence of external flow of the active liquid and/or of the bodily fluid or of any liquid present in the body cavity in question, throughout the time that said device is present or held in this cavity, simply by constriction thereof. [0006]
  • To this end, according to the invention, the disposable device has sufficient intrinsic consistency that it can be inserted into the body cavity by pushing, and comprises: [0007]
  • a central element at the source of at least part of the active liquid, in that it comprises a substrate which is relatively solid at ambient temperature and outside the body cavity, and becomes relatively liquid or fluid inside this same cavity and at body temperature so that within this cavity the central element liquefies at least partially to generate at least part of the liquid phase of the active liquid, [0008]
  • a peripheral element arranged around the central element, in the solid state, comprising a pad designed to collect and absorb the active liquid which has circulated into the body cavity by expanding and thus coming to press in a sealed manner against the mucous membrane of the body cavity.[0009]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • The present invention is now described by way of nonlimiting example with reference to the schematic appended drawing in which: [0010]
  • FIG. 1 depicts a disposable device according to the invention, in position in a body cavity, and just after it has been inserted into the latter by pushing, this being according to a first embodiment of the invention; FIG. 1 is an axial section through a device according to the invention, the latter having symmetry of revolution about an axis; [0011]
  • FIGS. [0012] 2 to 4 respectively depict three other embodiments of the present invention, still in axial section;
  • FIG. 5 depicts another embodiment of the present invention, still in axial section.[0013]
  • DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
  • According to FIG. 1, a disposable device according to the invention is referenced by the [0014] numerical reference 1. In general, it allows an active liquid as previously defined to be dispensed or released into a body cavity denoted by the numerical reference 2. This device has an intrinsic and overall consistency which is relatively firm but soft and stiff or strong enough to allow it to be inserted into the cavity by pushing, without altering the structure of said device, particularly without dissociating its various components and/or rupturing any liquid-containing capsule that may be contained inside said device (cf. embodiment according to FIG. 4).
  • The device according to the invention essentially comprises two components assembled together permanently, namely: [0015]
  • a [0016] central element 3 at the source of at least part of the active liquid as previously defined;
  • and a peripheral element [0017] 4 arranged around the central element 3, comprising a pad 5 designed to absorb the active liquid which has circulated or been dispensed into the body cavity, by expanding and thus coming to press in a relatively sealed manner against the mucous membrane of the body cavity (cf. shape depicted in dotted line in FIG. 1).
  • The [0018] central element 3 comprises a substrate, for example based on gelatin, which is relatively solid at ambient temperature and outside the body cavity and which becomes relatively liquid inside the body cavity and at body temperature so that within this cavity the central element liquefies at least partially to generate at least part of the liquid phase of the active liquid.
  • The gelatin may be replaced by any other substrate with the same properties, for example a lipid. [0019]
  • In consequence, according to one essential feature of the present invention, it is therefore the substrate of the central element which, by liquefaction within the body cavity, and therefore within the human body or the body of the animal, makes it possible to obtain all or part of the liquid phase of the active liquid. [0020]
  • As a preference, an agent for treating the body cavity as previously described is distributed discretely in the solid substrate of the central element, this being so regardless of the physical form or nature of said treatment agent outside the substrate, for example an oily, solid or liquid physical form, or whether it is hydrophobic or hydrophilic by nature. This discrete distribution of the treatment agent may be achieved by incorporating this agent into the previously defined substrate in the liquid phase when the disposable device according to the invention is being manufactured. [0021]
  • As clearly shown in FIG. 1, the [0022] central element 3 is a kind of molded part, molded by the solidification of the liquid substrate, for example the gelatin. And the pad 5 is a sleeve also molded or shaped from a material capable of absorbing a liquid or a fluid as it expands. This material is, for example, a foam of a biocompatible plastic material or alternatively a fibrous material (for example of the cellulose type), opened (for example folded) around the central element 3. The central element 3 and the peripheral element 4 are thus tailored to one another so that they fit together by simple axial pushing of the central element toward the peripheral element or vice versa.
  • The peripheral element [0023] 4 has a hole 4 a, or bore, particularly a blind hole as shown in FIG. 1, the shape and size of which are tailored correspondingly to receive the body 3 a of the central element 3. The head 3 b of the central element 3, of convex external shape, for example spherical, has a collar 6 while the peripheral element 4 has a neck 7, the shape and size of which are tailored to definitively retain the collar 6, by axially pushing the central element 3 and peripheral element 4 together. As shown in FIG. 1, the neck 7 has an undercut accommodating the collar 6 directed inward, and also of convex external shape, for example spherical. The foot 3 c of the central element 3 has a bulging shape, while the peripheral element 4 has a correspondingly flared part 4 d, the shape and size of which are tailored to retain the foot 3 c of the central element 3.
  • The absorbent material of the [0024] pad 5 can expand and/or is spongy and consists, for example, of filaments, capillary fibers, or natural fibers (cellulose or viscose for example), etc. As mentioned earlier, it is the liquefaction or melting of the substrate of the central element 3 which, generating at least part of the liquid phase of the active liquid within the body cavity 2, then allows the pad 5 to expand by collecting said liquid therein, this being the case at body temperature and inside the body cavity 2.
  • In order possibly to recycle the active liquid in contact with the [0025] body cavity 2, the pad 5 is bored for example with four radial passages 11 in a cross configuration, located below the hole 4 a, opening onto the exterior face of the pad 5 and possibly communicating with the bottom of the hole 4 a.
  • According to FIG. 2, the [0026] collar 6 extends toward the foot 3 c of the central element 3 in the form of a skirt 6 a capping the part 4 b of the peripheral element 4 away from the neck 7.
  • Moreover, still according to FIG. 2, a [0027] string 12 attached to the peripheral element 4 allows the disposable device 1 to be extracted from the body cavity 2 after it has treated the latter, that is to say after the substrate of the central element 3 has liquefied.
  • According to FIG. 3, a closed temporary [0028] protective case 10 encases the central element 3 and peripheral element 4 when these elements are assembled, as described earlier. This casing consists, for example, of a substrate with the properties described above, for example based on gelatin. What this means is that the casing is made of a material which is relatively solid at ambient temperature and outside the body cavity so that within this cavity and at the body temperature, this material melts and thus constitutes another part of the liquid phase of the active liquid previously defined. However, this casing 10 may consist of a hard and solid excipient, for example sucrose, as used in a galenic form to obtain sugar-coated pills, and capable of dissolving or breaking up in contact with any bodily liquid present in the cavity 2.
  • According to FIG. 4, the [0029] central element 3 is a capsule, the wall 8 of which consists of the previously defined substrate and the interior of which contains another liquid 15, active or otherwise, the wall 8 being closed and sealed at ambient temperature and outside the body. The liquid thus contained in the capsule makes it possible to increase the amount of liquid phase of the active liquid. This liquid 15 may have any appropriate form, for example oily, and may contain all or part of a treatment agent as previously described, in solution or in suspension in said liquid.
  • As depicted in FIG. 5, the [0030] casing 10 depicted in FIG. 4 may be omitted, while the wall 8 forms an appendage 13 that can be broken off at its opposite end of the pad 5, which allows the user to open the capsule just before inserting the device into the body cavity and to benefit from a small amount of the liquid 15 to moisten the exterior of said device at the time of inserting it into said cavity.
  • According to FIGS. [0031] 1 to 4, a device according to the invention, prior to its insertion into the body cavity 2, comprises a distal part 1 a, via which it is inserted into the body cavity 2, and a proximal part 1 b, the largest transverse diameter of which is smaller than the largest transverse diameter of the distal part 1 a. This allows the device to be held temporarily in the cavity before the active liquid takes over by swelling the pad 5.
  • This configuration also makes it possible to limit or eliminate any contact between the mucous membrane of the [0032] body cavity 2 and the absorbent material when the pad 5 is in the dry state at the time of insertion of the device 1; as such contact could not only give rise to a not insignificant amount of friction but may also be a source of discomfort or pain to the user. On the other hand, by virtue of the configuration adopted, it is only the distal part 1 a, covered with the relatively slippery collar 7, which slides in contact with the mucous membrane of the body cavity as the device is being inserted.
  • A disposable device as previously described affords the following essential advantages: [0033]
  • the absorption of the treatment agent or agents by the mucous membrane of the body cavity is more complete and rapid; [0034]
  • the incorporation of this treatment agent into the substrate of the central element makes it possible to have a precise and uniform amount of treatment agent which is also protected by the substrate, this keeping it away from any oxidation or hydrolysis, for example; [0035]
  • the mucous membrane of the cavity and the active liquid are brought fully into contact with each other. [0036]

Claims (26)

What is claimed is:
1. A disposable device, for transferring an active liquid into a body cavity, having sufficient intrinsic consistency to allow it to be inserted into said cavity by pushing, said device comprising:
a central element comprising a source of at least part of the active liquid;
a peripheral element arranged around the central element, comprising a pad designed to collect and absorb active liquid dispensed into the body cavity by expanding and thus coming to press in a sealed manner against mucous membrane of the body cavity;
wherein the central element is a capsule comprising a wall, and the interior of said capsule contains said active liquid, said wall being closed and sealed with respect to said active liquid, at ambient temperature and outside the body cavity; and
said wall forms an appendage that can be removed to open said source of liquid just before the device is inserted into the body cavity.
2. The device according to claim 1, wherein the active liquid comprises a treatment agent selected from the group consisting of wetting agents, agents for solubilizing and fluidizing a bodily fluid or liquid present in the body cavity, therapeutic agents, prophylactic agents, diagnostic agents, cosmetic agents, personal hygiene agents, antiseptics, bactericides, fungicides and spermicides.
3. The device according to claim 1, wherein the peripheral element has a hole, the shape and size of said hole being tailored to receive a body of the central element.
4. The device according to claim 1, wherein the central element has a foot with a bulging shape, while the peripheral element has a flared part, the shape and size of said flared part being tailored to retain the foot of the central element.
5. The device according to claim 3, wherein the pad is bored with at least one radial passage opening onto an exterior face of said pad, and communicating with said hole.
6. The device according to claim 1, wherein the appendage is removable by breaking off the appendage from the wall.
7. A device for transferring a liquid into a body cavity, comprising:
an expandable element that is expandable upon absorption of liquid, said expandable element having a distal end and a proximal end;
a source of liquid at least partially radially surrounded by said expandable element, said source of liquid comprising a wall that is closed and sealed while said device is outside said body cavity, and said wall encloses a substance that is liquid in ambient temperature; and
said wall forms an appendage that can be removed to open said source of liquid just before the device is inserted into the body cavity.
8. A device according to claim 7, wherein said source of liquid extends distally beyond a distal end of said expandable element.
9. A device according to claim 7, wherein said source of liquid extends from within a proximal half of said expandable element through a distal half of said expandable element.
10. A device according to claim 7, wherein said wall comprises a substance that is relatively solid in ambient temperature and atmosphere, but that can at least partially enter a liquid state when in a body cavity.
11. A device according to claim 10, wherein said substance at least partially melts and/or dissolves under conditions in said body cavity.
12. The device according to claim 7, wherein the appendage is removable by breaking off the appendage from the wall.
13. A device according to claim 7, wherein said expandable element comprises a foam of a biocompatible plastic material.
14. The device according to claim 7, further comprising a material that at least partially covers said distal end of said expandable element and said source of liquid, said material comprising a substance that is relatively solid in ambient temperature and atmosphere, but that can at least partially enter a liquid state when in a body cavity.
15. The device according to claim 14, wherein said material at least partially melts and/or dissolves under conditions in said body cavity.
16. A device according to claim 14, wherein said material covers an exposed portion of said central element.
17. A device according to claim 7, wherein said substance is a liquid that comprises a local treatment agent.
18. A device according to claim 7, wherein said substance is a liquid that comprises a systemic treatment agent.
19. A device according to claim 7, wherein said substance is a liquid that comprises at least one member selected from the group consisting of antiseptics, bactericides, spermicides and fungicides.
20. A device for transferring a liquid into a body cavity, comprising:
an expandable element that is expandable upon absorption of liquid, said expandable element having a distal end and a proximal end and comprising a foam of a biocompatible plastic material;
a source of liquid at least partially radially surrounded by said expandable element and extending from within a proximal half of said expandable element through and beyond a distal half of said expandable element, said source of liquid comprising a wall that is closed and sealed while said device is outside said body cavity, and said wall enclosing a substance that is liquid in ambient temperature and forming an appendage that can be removed to open said source of liquid; and
a material that at least partially covers said distal end of said expandable element and said source of liquid, said material comprising a substance that is relatively solid in ambient temperature and atmosphere, but that can at least partially enter a liquid state when in a body cavity.
21. A method of transferring a liquid into a vagina, comprising removing the appendage from a device according to claim 1, and inserting said device into and in contact with walls of said vagina, allowing said liquid to be released from said source of liquid in said vagina, and withdrawing said device from said vagina.
22. A method according to claim 21, wherein a proximal end of said expandable element expands to press in a sealed manner against said walls of said vagina upon absorbing said liquid, to seal against external flow of the liquid from the vagina.
23. A method of transferring a liquid into a vagina, comprising removing the appendage from a device according to claim 7, and inserting said device into and in contact with walls of said vagina,)allowing said liquid to be released from said source of liquid in said vagina, and withdrawing said device from said vagina.
24. A method according to claim 23, wherein said proximal end of said expandable element expands to press in a sealed manner against said walls of said vagina upon absorbing said liquid, to seal against external flow of the liquid from the vagina.
25. A method of transferring a liquid into a vagina, comprising removing the appendage from a device according to claim 20, and inserting said device into and in contact with walls of said vagina, allowing said liquid to be released from said source of liquid in said vagina, and withdrawing said device from said vagina.
26. A method according to claim 25, wherein said proximal end of said expandable element expands to press in a sealed manner against said walls of said vagina upon absorbing said liquid, to seal against external flow of the liquid from the vagina.
US10/400,446 1999-02-03 2003-03-28 Disposable device for transferring an active liquid into a body cavity Abandoned US20030191439A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/400,446 US20030191439A1 (en) 1999-02-03 2003-03-28 Disposable device for transferring an active liquid into a body cavity

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9901419A FR2788987B1 (en) 1999-02-03 1999-02-03 SINGLE-USE DEVICE FOR TRANSFERRING AN ACTIVE LIQUID IN AN INTRACORPOREAL CAVITY
FR99/01419 1999-02-03
US09/830,426 US6558362B1 (en) 1999-02-03 2000-02-02 Disposable device for transferring an active liquid into a body cavity
US10/400,446 US20030191439A1 (en) 1999-02-03 2003-03-28 Disposable device for transferring an active liquid into a body cavity

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US09/830,426 Division US6558362B1 (en) 1999-02-03 2000-02-02 Disposable device for transferring an active liquid into a body cavity
PCT/FR2000/000245 Division WO2000045887A1 (en) 1999-02-03 2000-02-02 Disposable device for transferring an active liquid into a body cavity

Publications (1)

Publication Number Publication Date
US20030191439A1 true US20030191439A1 (en) 2003-10-09

Family

ID=9541702

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/830,426 Expired - Fee Related US6558362B1 (en) 1999-02-03 2000-02-02 Disposable device for transferring an active liquid into a body cavity
US10/400,446 Abandoned US20030191439A1 (en) 1999-02-03 2003-03-28 Disposable device for transferring an active liquid into a body cavity

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/830,426 Expired - Fee Related US6558362B1 (en) 1999-02-03 2000-02-02 Disposable device for transferring an active liquid into a body cavity

Country Status (11)

Country Link
US (2) US6558362B1 (en)
EP (1) EP1150737A1 (en)
JP (1) JP2002536082A (en)
CN (1) CN1338957A (en)
AU (1) AU763780B2 (en)
BR (1) BR0007981A (en)
CA (1) CA2361491A1 (en)
FR (1) FR2788987B1 (en)
HK (1) HK1043948A1 (en)
NO (1) NO20013793L (en)
WO (1) WO2000045887A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070255232A1 (en) * 2001-10-16 2007-11-01 Bernard Chaffringeon Disposable device and method for transferring an active liquid into a body cavity
US20070293837A1 (en) * 2006-06-16 2007-12-20 Sokal David C Vaginal drug delivery system and method
US20080083942A1 (en) * 2006-09-28 2008-04-10 Esin Terzioglu Single-Poly Non-Volatile Memory Cell
US20080132868A1 (en) * 2006-11-08 2008-06-05 Playtex Products, Inc. Tampon pledget for increased bypass leakage protection

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1992385A3 (en) * 2001-10-16 2011-03-09 Bernard Chaffringeon A disposable device for transferring and/or circulating an active liquid into and/or inside an intracorporeal cavity
FR2830748B1 (en) * 2001-10-16 2004-01-30 Bernard Chaffringeon SINGLE USE DEVICE FOR TRANSFERRING AND CIRCULATING AN ACTIVE LIQUID IN AN INTRACORPOREAL CAVITY
US6932805B2 (en) * 2002-03-18 2005-08-23 The Procter & Gamble Company Shaped tampon
US8247642B2 (en) * 2004-05-14 2012-08-21 Mcneil-Ppc, Inc. Fluid management device with fluid transport element for use within a body
US8480833B2 (en) * 2004-05-14 2013-07-09 Mcneil-Ppc, Inc. Intravaginal device with fluid transport plates and methods of making
US8653322B2 (en) * 2004-05-14 2014-02-18 Mcneil-Ppc, Inc. Intravaginal device with fluid transport plates
JP5117186B2 (en) * 2004-05-14 2013-01-09 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド Intravaginal device with fluid transfer element
US20050256485A1 (en) 2004-05-14 2005-11-17 Samuel Carasso Method of using intravaginal device with fluid transport plates
US7618403B2 (en) 2004-05-14 2009-11-17 Mcneil-Ppc, Inc. Fluid management device with fluid transport element for use within a body
US20050256484A1 (en) * 2004-05-14 2005-11-17 Chase David J Method of using an intravaginal device with fluid transport plates
US20050277904A1 (en) * 2004-05-14 2005-12-15 Chase David J Tampon with flexible panels
US7845380B2 (en) * 2004-05-14 2010-12-07 Mcneil-Ppc, Inc. Intravaginal device with fluid transport plates
US8864640B2 (en) * 2004-05-14 2014-10-21 Mcneil-Ppc, Inc. Methods of packaging intravaginal device
EP1700588A1 (en) * 2005-03-09 2006-09-13 Björn Andersch Tampon
US7993667B2 (en) * 2005-03-25 2011-08-09 Kimberly-Clark Worldwide, Inc. Methods of manufacturing a medicated tampon assembly
US7744556B2 (en) * 2005-03-25 2010-06-29 Kimberly-Clark Worldwide, Inc. Delivery tube assembly for an applicator
US7527614B2 (en) * 2005-03-25 2009-05-05 Kimberly-Clark Worldwide, Inc. Protective tube for a medicated tampon
US7919453B2 (en) * 2005-03-25 2011-04-05 Kimberly-Clark Worldwide, Inc. Dosage cap assembly for an applicator
US9295289B2 (en) * 2005-04-01 2016-03-29 Leslie Jane James Waist-fastening, hip-encompassing apparel with at least one concealed storage compartment
US7708726B2 (en) * 2005-04-28 2010-05-04 Kimberly-Clark Worldwide, Inc. Dosage form cap for an applicator
US20070141118A1 (en) * 2005-12-15 2007-06-21 Damico Joyce A Layered dosage form for a medicated tampon assembly
US20070156077A1 (en) * 2005-12-30 2007-07-05 Pfister Margaret M Personal hygiene system and methods
US7824383B2 (en) * 2006-06-16 2010-11-02 Family Health International Vaginal drug delivery system and method
FR3052655B1 (en) 2016-06-17 2018-07-13 Laboratoires Innothera DEVICE FOR MEASURING A MEASUREMENT
US10799399B1 (en) * 2018-05-09 2020-10-13 Sonya D. Whack Time-released tampon applicator
US20200323699A1 (en) * 2019-04-11 2020-10-15 Herphoric, LLC Medication Delivery Device and Method
CA3207593A1 (en) 2019-08-15 2021-02-15 Better Made Hemp, LLC Absorbent article

Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US706778A (en) * 1901-12-03 1902-08-12 Edmund Morse Pond Medicated tampon.
US812769A (en) * 1904-07-19 1906-02-13 Edmund M Pond Medicated tampon.
US1561020A (en) * 1922-07-25 1925-11-10 Arthur H Smith Frectal tampon
US1575123A (en) * 1922-08-01 1926-03-02 Martocci-Pisculli Leon Medical appliance
US1732413A (en) * 1927-05-16 1929-10-22 Motteram Etta Medical pessary
US1887526A (en) * 1931-11-02 1932-11-15 Joseph M Spielberg Medical tampon
US2493416A (en) * 1947-07-17 1950-01-03 A Gazzoni & Co Soc Odontalgic device
US3512527A (en) * 1966-10-17 1970-05-19 Marguerite Desoye Dressing,in particular for natural cavities of the human body
US3515138A (en) * 1967-07-05 1970-06-02 Josef Hochstrasser Process and apparatus for treating elongated deformable articles
US3519364A (en) * 1968-02-02 1970-07-07 Andrew Truhan Applicator
US3521637A (en) * 1967-11-28 1970-07-28 Nelson J Waterbury Tampon or similar sanitary napkin containing vitamin a
US3559646A (en) * 1968-08-16 1971-02-02 Joseph Mullan Tampon
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3902493A (en) * 1974-05-13 1975-09-02 Procter & Gamble Medicated catamenial tampon
US3918452A (en) * 1974-08-01 1975-11-11 Edward Cornfeld Tampons impregnated with contraceptive compositions
US4136680A (en) * 1976-06-04 1979-01-30 Transmed Corp. Self-contained apparatus for collection and maintenance of medical specimen and methods of using same
US4232673A (en) * 1975-08-11 1980-11-11 Louis Bucalo Method for collecting and processing body fluids
US4257427A (en) * 1973-02-05 1981-03-24 Louis Bucalo Method for collecting body fluids
US4286596A (en) * 1978-02-27 1981-09-01 Herbert Rubinstein Tampon containing a liquid medicant
US4317454A (en) * 1977-08-04 1982-03-02 Louis Bucalo Methods and devices for obtaining specimens and for signalling when the specimen has been collected
US4318405A (en) * 1980-07-24 1982-03-09 Sneider Vincent R Tampon and drug delivery device
US4324262A (en) * 1979-01-02 1982-04-13 University Of Virginia Alumni Patents Foundation Aspirating culture catheter and method of use
US4335720A (en) * 1980-04-09 1982-06-22 Glassman Jacob A Catamenial tampon with hollow core
US4582717A (en) * 1982-02-06 1986-04-15 Bayer Aktiengesellschaft Process for production of vaginal tampons containing pharmaceutical active compound
US4858624A (en) * 1988-02-24 1989-08-22 Vance Products Incorporated D/B/A/ Cook Urological Incorporated And Cook Ob/Gyn Device and method for intravaginal, barrier-type prevention of conception and infection
US5273521A (en) * 1992-08-26 1993-12-28 Peiler Frances K Tampon applicator for delivery of a medicament
US5282789A (en) * 1992-09-15 1994-02-01 Niemand Industries, Inc. Disposable medicine applicator
US5299581A (en) * 1990-07-05 1994-04-05 Donnell John T Intravaginal device
US5357977A (en) * 1993-04-23 1994-10-25 St. Mary's Hospital And Medical Center, Inc. Cytological sampling method and device
US5542914A (en) * 1993-02-12 1996-08-06 Kimberly-Clark Corporation Encapsulated tampon with an applicator
US5810745A (en) * 1994-09-19 1998-09-22 Chaffringeon; Bernard Single-use body fluid analysis device
US5823954A (en) * 1994-09-22 1998-10-20 Chaffringeon; Bernard Single-use device for detecting or analyzing a body fluid
US5830199A (en) * 1994-03-29 1998-11-03 Chaffringeon; Bernard Disposable device for recovery, and if appropriate analysis, of a body fluid
US5840055A (en) * 1994-11-21 1998-11-24 Bernard Chaffringeon Disposable device for transfer of an active liquid into an intracorporeal cavity
US6059735A (en) * 1995-11-20 2000-05-09 Bernard Chaffringeon Portable device for extemporaneous analysis of a body-fluid
US6068899A (en) * 1997-03-17 2000-05-30 The Proctor & Gamble Company Tampon packaging system

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA827582B (en) * 1981-11-06 1983-08-31 Ansell Inc Spermicidal condom
EP0093740A1 (en) 1981-11-17 1983-11-16 Portland Surgical Products Pty. Ltd. Catheter-type sampling device
DE3629994A1 (en) * 1986-09-03 1988-03-17 Weissenbacher Ernst Rainer Pro Device for administration of medicaments in body cavities or on body surfaces
GB2254002B (en) * 1991-01-16 1995-03-22 Controlled Therapeutics Retrievable pessary

Patent Citations (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US706778A (en) * 1901-12-03 1902-08-12 Edmund Morse Pond Medicated tampon.
US812769A (en) * 1904-07-19 1906-02-13 Edmund M Pond Medicated tampon.
US1561020A (en) * 1922-07-25 1925-11-10 Arthur H Smith Frectal tampon
US1575123A (en) * 1922-08-01 1926-03-02 Martocci-Pisculli Leon Medical appliance
US1732413A (en) * 1927-05-16 1929-10-22 Motteram Etta Medical pessary
US1887526A (en) * 1931-11-02 1932-11-15 Joseph M Spielberg Medical tampon
US2493416A (en) * 1947-07-17 1950-01-03 A Gazzoni & Co Soc Odontalgic device
US3512527A (en) * 1966-10-17 1970-05-19 Marguerite Desoye Dressing,in particular for natural cavities of the human body
US3515138A (en) * 1967-07-05 1970-06-02 Josef Hochstrasser Process and apparatus for treating elongated deformable articles
US3521637A (en) * 1967-11-28 1970-07-28 Nelson J Waterbury Tampon or similar sanitary napkin containing vitamin a
US3519364A (en) * 1968-02-02 1970-07-07 Andrew Truhan Applicator
US3559646A (en) * 1968-08-16 1971-02-02 Joseph Mullan Tampon
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US4257427A (en) * 1973-02-05 1981-03-24 Louis Bucalo Method for collecting body fluids
US3902493A (en) * 1974-05-13 1975-09-02 Procter & Gamble Medicated catamenial tampon
US3918452A (en) * 1974-08-01 1975-11-11 Edward Cornfeld Tampons impregnated with contraceptive compositions
US4232673A (en) * 1975-08-11 1980-11-11 Louis Bucalo Method for collecting and processing body fluids
US4136680A (en) * 1976-06-04 1979-01-30 Transmed Corp. Self-contained apparatus for collection and maintenance of medical specimen and methods of using same
US4317454A (en) * 1977-08-04 1982-03-02 Louis Bucalo Methods and devices for obtaining specimens and for signalling when the specimen has been collected
US4286596A (en) * 1978-02-27 1981-09-01 Herbert Rubinstein Tampon containing a liquid medicant
US4324262A (en) * 1979-01-02 1982-04-13 University Of Virginia Alumni Patents Foundation Aspirating culture catheter and method of use
US4335720A (en) * 1980-04-09 1982-06-22 Glassman Jacob A Catamenial tampon with hollow core
US4318405A (en) * 1980-07-24 1982-03-09 Sneider Vincent R Tampon and drug delivery device
US4582717A (en) * 1982-02-06 1986-04-15 Bayer Aktiengesellschaft Process for production of vaginal tampons containing pharmaceutical active compound
US4858624A (en) * 1988-02-24 1989-08-22 Vance Products Incorporated D/B/A/ Cook Urological Incorporated And Cook Ob/Gyn Device and method for intravaginal, barrier-type prevention of conception and infection
US5299581A (en) * 1990-07-05 1994-04-05 Donnell John T Intravaginal device
US5273521A (en) * 1992-08-26 1993-12-28 Peiler Frances K Tampon applicator for delivery of a medicament
US5282789A (en) * 1992-09-15 1994-02-01 Niemand Industries, Inc. Disposable medicine applicator
US5542914A (en) * 1993-02-12 1996-08-06 Kimberly-Clark Corporation Encapsulated tampon with an applicator
US5357977A (en) * 1993-04-23 1994-10-25 St. Mary's Hospital And Medical Center, Inc. Cytological sampling method and device
US5830199A (en) * 1994-03-29 1998-11-03 Chaffringeon; Bernard Disposable device for recovery, and if appropriate analysis, of a body fluid
US5810745A (en) * 1994-09-19 1998-09-22 Chaffringeon; Bernard Single-use body fluid analysis device
US5823954A (en) * 1994-09-22 1998-10-20 Chaffringeon; Bernard Single-use device for detecting or analyzing a body fluid
US5840055A (en) * 1994-11-21 1998-11-24 Bernard Chaffringeon Disposable device for transfer of an active liquid into an intracorporeal cavity
US6059735A (en) * 1995-11-20 2000-05-09 Bernard Chaffringeon Portable device for extemporaneous analysis of a body-fluid
US6068899A (en) * 1997-03-17 2000-05-30 The Proctor & Gamble Company Tampon packaging system

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070255232A1 (en) * 2001-10-16 2007-11-01 Bernard Chaffringeon Disposable device and method for transferring an active liquid into a body cavity
US20070293837A1 (en) * 2006-06-16 2007-12-20 Sokal David C Vaginal drug delivery system and method
US8137327B2 (en) 2006-06-16 2012-03-20 Family Health International Vaginal drug delivery system and method
US20080083942A1 (en) * 2006-09-28 2008-04-10 Esin Terzioglu Single-Poly Non-Volatile Memory Cell
US7440311B2 (en) * 2006-09-28 2008-10-21 Novelics, Llc Single-poly non-volatile memory cell
US20080132868A1 (en) * 2006-11-08 2008-06-05 Playtex Products, Inc. Tampon pledget for increased bypass leakage protection
US7867209B2 (en) 2006-11-08 2011-01-11 Playtex Products, Inc. Tampon pledget for increased bypass leakage protection

Also Published As

Publication number Publication date
AU763780B2 (en) 2003-07-31
NO20013793D0 (en) 2001-08-02
EP1150737A1 (en) 2001-11-07
US6558362B1 (en) 2003-05-06
FR2788987B1 (en) 2001-05-04
CA2361491A1 (en) 2000-08-10
FR2788987A1 (en) 2000-08-04
BR0007981A (en) 2001-11-06
AU2301900A (en) 2000-08-25
NO20013793L (en) 2001-09-26
CN1338957A (en) 2002-03-06
JP2002536082A (en) 2002-10-29
HK1043948A1 (en) 2002-10-04
WO2000045887A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
US6558362B1 (en) Disposable device for transferring an active liquid into a body cavity
US5299581A (en) Intravaginal device
US4286596A (en) Tampon containing a liquid medicant
US20070255232A1 (en) Disposable device and method for transferring an active liquid into a body cavity
CA1231602A (en) Devices for insertion into a body cavity of an animal and/or applicators therefor
US4553965A (en) Fluid-expansible contraceptive tampon and applicator
US5840055A (en) Disposable device for transfer of an active liquid into an intracorporeal cavity
US4271835A (en) Fluid-expansible contraceptive tampon and applicator
JPH06245957A (en) Capsuled tampon for menses with applicator and without applicator
US7112184B2 (en) Disposable vaginal cleaning device
MXPA97003691A (en) Disposable device for the transfer of an active liquid to an intracorous cavity
US4200101A (en) Catamenial tampon
US2110962A (en) Medical device
US11382799B2 (en) Tampon with intravaginal cannabinoid delivery device
US7060057B2 (en) Comfortable tampon
USRE21943E (en) Medical device
EP0071599A1 (en) Fluid expansible contraceptive tampon and applicator
MXPA01007831A (en) Disposable device for transferring an active liquid into a body cavity
JP2001520538A (en) Transurethral device
GB2064326A (en) Tampons
WO2004087026A1 (en) Method for obtaining a disposable device for transferring and/or circulating an active liquid into and/or inside an intracorporal cavity
EP1455886B1 (en) A disposable devce for transferring and/or circulating an active liquid into and/or inside an intracorporeal cavity
CA2070426C (en) Feminine hygiene device
CA1171603A (en) Fluid expansible contraceptive tampon and applicator
AU2002350987A1 (en) A disposable device for transferring and/or circulating an active liquid into and/or inside an intracorporeal cavity

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO PAY ISSUE FEE